Moreover, we determined CD44/CD24 expression for breast and CD44/CD133/CD326 expression for colon cancer cell lines to study the proportion of cancer cells with a CSC phenotype in the different subpopulations. This evidence concerns the gene EPCAM and colonic neoplasm.